MedPath

Evaluating how feasible a new mobile phone application is for reducing sitting behaviour and improving blood sugar levels in Type 2 diabetes

Not Applicable
Completed
Conditions
Nutritional, Metabolic, Endocrine
Type 2 diabetes
Type 2 diabetes mellitus
Registration Number
ISRCTN11167977
Lead Sponsor
niversity of Bedfordshire
Brief Summary

2020 results in https://doi.org/10.3390/ijerph17124414 (added 29/06/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Male or female
2. Aged 18-65 years
3. Diagnosed with Type 2 diabetes in the last 4 years
4. In the first stage (single non-insulin blood glucose lowering therapy) or first intensification (dual treatment of metformin plus one other drug) of drug treatment or using a diet and exercise management strategy
5. Speak and read English
6. Body mass index (BMI) < 40 kg/m2

Exclusion Criteria

1. Type 1 diabetes
2. Diseases or disorders related to diabetes (e.g. heart disease, damage to the retina at the back of the eye, kidney problems, and infections, ulcers or reduced ability to feel pain in feet)
3. Type 2 diabetes diagnosed more than 4 years ago
4. Pregnant
5. Severe obesity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.